;IFEC"), with the assistance or facilitation of T&S Inter Product Life Company Limited ("T&S"), Mr. Pannawit Jaturapornsawat who is an authorized director of T&S and Mr
115 mn in 1Q20 and THB 124 mn in 2Q20 (for the first six months of 2020, the amount is approximately THB 239 mn) • In 2Q20, The Company recognized an insurance claim on CentralwOrld fire, amount THB 280
115 mn in 1Q20 and THB 124 mn in 2Q20 (for the first six months of 2020, the amount is approximately THB 239 mn) • In 2Q20, The Company recognized an insurance claim on CentralwOrld fire, amount THB 280
47.5% 26.4 7.9% Gain on loans receivable from purchase of accounts receivable 88.3 16.0% 232.8 30.5% 144.5 163.6% Insurance Income 37.3 6.8% 71.4 9.3% 34.1 91.4% Total Revenues 552.4 100.0% 764.4 100.0
;insurance ตามข้อหารือข้างต้นนี้เป็นการทำ insurance cover ความเสียหายกรณีที่มีการเลิกสัญญาเช่าซึ่งเป็นเหตุให้กอง 1 ไม่สามารถใช้สิทธิครอบครองอาคารได้ แต่ insurance 
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
decrease of 17.3% YoY, mainly due to the recognition of non-recurring income from the insurance claim under terrorism coverage of THB 3,500 mn in the prior year. Excluding the non-recurring items CPN